Development and Initial Characterization of the First 18 F-CXCR2-Targeting Radiotracer for PET Imaging of Neutrophils.
Philipp SpatzXinyu ChenKora ReichauMax E HuberSaskia MühligYohji MatsusakaMatthias SchiedelTakahiro HiguchiMichael DeckerPublished in: Journal of medicinal chemistry (2024)
The interleukin-8 receptor beta (CXCR2) is a highly promising target for molecular imaging of inflammation and inflammatory diseases. This is due to its almost exclusive expression on neutrophils. Modified fluorinated ligands were designed based on a squaramide template, with different modification sites and synthetic strategies explored. Promising candidates were then tested for affinity to CXCR2 in a NanoBRET competition assay, resulting in tracer candidate 16b . As direct 18 F-labeling using established tosyl chemistry did not yield the expected radiotracer, an indirect labeling approach was developed. The radiotracer [ 18 F] 16b was obtained with a radiochemical yield of 15% using tert -butyl ( S )-3-(tosyloxy)pyrrolidine carboxylate and a pentafluorophenol ester. The subsequent time-dependent uptake of [ 18 F] 16b in CXCR2-negative and CXCR2-overexpressing human embryonic kidney cells confirmed the radiotracer's specificity. Further studies with human neutrophils revealed its diagnostic potential for functional imaging of neutrophils.
Keyphrases
- pet imaging
- endothelial cells
- cell migration
- positron emission tomography
- oxidative stress
- induced apoptosis
- induced pluripotent stem cells
- poor prognosis
- high resolution
- pluripotent stem cells
- high throughput
- computed tomography
- cell death
- drug delivery
- binding protein
- cell cycle arrest
- cancer therapy
- signaling pathway
- pet ct
- climate change
- pi k akt
- endoplasmic reticulum stress